Clinical research across Eastern Europe

Therapeutic Areas

Experienced clinical research support across a broad range of indications and product types.

Discuss your study

Clinical research experience

Our teams are assigned based on relevant experience and the needs of each protocol. Contact us for a study-specific capability discussion.

Cardiology clinical research

Cardiology

Study support can be tailored to the protocol, phase, indication, country and sponsor oversight model.

Pulmonology clinical research

Pulmonology

Study support can be tailored to the protocol, phase, indication, country and sponsor oversight model.

Oncology clinical research

Oncology

Study support can be tailored to the protocol, phase, indication, country and sponsor oversight model.

Rheumatology clinical research

Rheumatology

Study support can be tailored to the protocol, phase, indication, country and sponsor oversight model.

Dermatology clinical research

Dermatology

Study support can be tailored to the protocol, phase, indication, country and sponsor oversight model.

Neurology clinical research

Neurology

Study support can be tailored to the protocol, phase, indication, country and sponsor oversight model.

Infectious diseases clinical research

Infectious diseases

Study support can be tailored to the protocol, phase, indication, country and sponsor oversight model.

Hematology clinical research

Hematology

Study support can be tailored to the protocol, phase, indication, country and sponsor oversight model.

Endocrinology clinical research

Endocrinology

Study support can be tailored to the protocol, phase, indication, country and sponsor oversight model.

Surgery clinical research

Surgery

Study support can be tailored to the protocol, phase, indication, country and sponsor oversight model.

Medical devices clinical research

Medical devices

Study support can be tailored to the protocol, phase, indication, country and sponsor oversight model.

Cosmetics clinical research

Cosmetics

Study support can be tailored to the protocol, phase, indication, country and sponsor oversight model.